Meanwhile, the threshold for DC activation declines while IFN-γ production and TILs proliferation increase, allowing for mobilized antigen-presenting ability, upregulated circulating lymphocytes recruitment, and robust effector cell priming, together resulting in immune potentiation and tumor regression (Figure 1A) (20, 59). The gene discussed is IFNG; the disease is neoplasm.